RHÖN-KLINIKUM Aktiengesellschaft (ETR:RHK) Stock Falls 1.4% – Should You Sell?

RHÖN-KLINIKUM Aktiengesellschaft (ETR:RHK – Get Free Report) was down 1.4% during mid-day trading on Thursday. The company traded as low as €14.30 and last traded at €14.30. Approximately 56 shares traded hands during trading, a decline of 100% from the average session volume of 43,281 shares. The stock had previously closed at €14.50.

RHÖN-KLINIKUM Aktiengesellschaft Price Performance

The firm has a market cap of $950.43 million, a P/E ratio of 21.18, a price-to-earnings-growth ratio of 26.77 and a beta of 0.06. The company has a debt-to-equity ratio of 9.17, a current ratio of 2.63 and a quick ratio of 2.12. The firm’s 50 day moving average is €14.52 and its 200 day moving average is €13.34.

About RHÖN-KLINIKUM Aktiengesellschaft

(Get Free Report)

RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, offers in-patient, semi-patient, and outpatient healthcare services in Germany. Its hospitals offer treatment services, including rehabilitation, ophthalmology, pregnancies and births, accident surgery, dentistry, tumors, neurological conditions, and treatment of thoracic, lung, vascular, nerves and the skeletal system, and heart diseases. The company was founded in 1973 and is based in Bad Neustadt an der Saale, Germany.

Recommended Stories

Receive News & Ratings for RHÖN-KLINIKUM Aktiengesellschaft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RHÖN-KLINIKUM Aktiengesellschaft and related companies with MarketBeat.com's FREE daily email newsletter.